(No ratings)
Dr. Joshua Alexander Fein, MD is a physician provider in New York, NY specializing in physician, oncology (cancer care) and hematology (blood disorders). He graduated from Tel Aviv University, Sackler Faculty of Medicine in 2019 and has 7 years of experience. Dr. Joshua Alexander Fein, MD is affiliated with NewYork-Presbyterian, Weill Cornell Medicine and Bone Marrow Transplant and Cell Therapy Program.
Dr. Joshua Alexander Fein, MD graduated from Tel Aviv University, Sackler Faculty of Medicine in 2019. He is certified by the Board Certification: internal medicine and has a state license in New York.
Medical School: Tel Aviv University, Sackler Faculty of Medicine (2019)
Board Certification: Board Certification: internal medicine
Licensed In: New York
Dr. Joshua Alexander Fein, MD appears to accept the following insurance providers: Health Insurance Plan of NY (HIP), EmblemHealth, Healthspring, WellCare, AETNA, United Healthcare, Oxford Health Plans, Medicare, CIGNA, Quality Health Management (QHM), Local 1199, Anthem Blue Cross/Blue Shield, UnitedHealthcare, GHI, Rockefeller University/Luminare, Aetna - NYP, Aetna PPO, United Healthcare Medicare, Aetna HMO, Aetna Medicare, Medicare Advantage, GHI CBP, United Healthcare Community Plan (AmeriChoice), United Healthcare Empire Plan, Aetna Weill Cornell Employee Managed Care Plan, Oxford Health Plans Metro/Core/Charter, Rockefeller University - Trustmark, Oxford Health Plans Freedom, Oxford Health Plans Liberty and Aetna-NYP EPO/POS.
According to our sources, Dr. Joshua Alexander Fein, MD accepts the following insurance providers:
Dr. Joshua Alexander Fein, MD does not have any reviews yet, be the first to leave a review of Dr. Joshua Alexander Fein, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Joshua Alexander Fein, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Sobi, Inc |
$2,765
GAMIFANT $2,765 |
|
|---|---|---|
| Illumina, Inc. |
$219
Oncology Testing $219 |
|
| AbbVie Inc. |
$116
Venclexta $116 |
|
| Incyte Corporation |
$75
JAKAFI $27 |
$48 |
| Regeneron Healthcare Solutions, Inc. |
$51
LIBTAYO $51 |
| Consulting Fee | $2,310 |
|---|---|
| Food and Beverage | $917 |
Joshua A. Fein, M.D., is an Assistant Professor of Medicine within the Division of Hematology and Medical Oncology at Weill Cornell Medicine and serves as the Chair of Quality Assurance and Director of Informatics for the Bone Marrow Transplant and Cellular Therapy Program and Assistant Attending physician at NewYork-Presbyterian Hospital. Dr. Fein’s clinical interest is in caring for individuals undergoing stem cell transplantation to treat leukemia and other disease of the blood and bone marrow. Dr. Fein received his Bachelor of Music in 2008 from the Eastman School of Music at the University of Rochester, where he trained as an operatic baritone. He continued his musical training in Germany at the Hochschule für Musik Karlsruhe, where he received a Master of Singing degree in 2011. Upon returning to the United States, Dr. Fein’s focus shifted to pursuing medical training, and he obtained his medical degree from the American Program at Tel Aviv University in Israel. During his medical studies, Dr. Fein began to research hematopoietic cell transplantation under the mentorship of Profs. Roni Shouval and Arnon Nagler at Sheba Medical Center in Ramat Gan, Israel, leading to publications and international presentations, many in collaboration with the European Society for Blood and Marrow Transplantation. He completed a residency in Internal Medicine at the University of Connecticut and hematology/oncology fellowship at Weill Cornell Medicine/NewYork- Presbyterian. His research in the transplant field has led to over 30 publications in journals including first-author publications in the Journal of Clinical Oncology and The Lancet Haematology. He is the recipient of the prestigious Research Training Award for Fellows from the American Society of Hematology and, more recently, holds a KL2 award supporting his ongoing investigation of the recovery of a healthy immune system after undergoing donor stem cell transplantation.